![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » CHINA BIOPHARMA APPOINTS DR. YIMIN YU
CHINA BIOPHARMA APPOINTS DR. YIMIN YU
April 20, 2006
Techedge Inc. announced that China BioPharma, Ltd. has appointed Dr. Yimin Yu, the current Chairman of HYTE Research, LLC to the company's Board of Advisors. Peter Wang commented, "Dr. Yu brings substantial experience to our Board of Advisors in the areas of technology transfer and cGMP (current good manufacturing practices), which are used by pharmaceutical manufacturers as they produce and test products for human use."
Genetic Engineering News (http://www.genengnews.com/news/bnitem.aspx?name=607169)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct